abstract |
Disclosed is 5-(3,3-dimethyl-but -1-ynyl )-3-[(trans-4-hydroxy-cyclohexyl)-(trans-4-methylcyclohexanecarbonyl)-amino]-thiophene-2-carboxylic acid or a pharmaceutically acceptable salt thereof. A composition comprising this compound, pegylated interferon-alpha and ribavirin is also disclosed. Use of the composition for treating hepatitis C viral infection is also disclosed. |